Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 1/2 1Phase 1 1

Status

Recruiting 14Unknown 5Active not recruiting 4Terminated 3Not yet recruiting 3Completed 2Withdrawn 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 19Lymphoid 13Plasma cell 4Thoracic 3Other solid neoplasm 3Genitourinary 3Gastrointestinal 3CNS 3Head & Neck 2Gynecologic 2Breast 2Sarcoma 1Other neoplasm 1Myeloid 1Classical hematology 1

Conditions

KRAS G12V 1HER2+ Advanced Breast Cancer 1Adult Solid Tumor 1

Interventions

Injections 9Interviews as Topic 4Cisplatin 4Carboplatin 4toripalimab 3fludarabine 3envafolimab 3Pemetrexed 3Iodine-125 3Immune Checkpoint Inhibitors 3Fluorodeoxyglucose F18 3tislelizumab 2pembrolizumab 2Paclitaxel 2Oxaliplatin 2Drug Therapy 2Cyclophosphamide 2Cryosurgery 2Capecitabine 2Blood Specimen Collection 2trastuzumab deruxtecan 1spartalizumab 1somatostatin receptor 2 1regorafenib 1olaparib 1nabiximols 1malic acid 1lenvatinib 1ivarmacitinib 1irinotecan sucrosofate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Not yet recruiting × fludarabine × Other solid neoplasm × Clear all
NCT07342738 2026-01-15

TCR-T Cell Therapy for KRAS Mutation in Advanced Solid Tumors

Sun Yat-sen University

Phase EARLY_PHASE1 Not yet recruiting
25 enrolled
Other solid neoplasm

KRAS G12V

NCT06027983 2025-09-23

Chimeric Receptor T Cells With Trastuzumab in HER2+ Advanced Breast Cancer and Other Solid Tumors

National University Hospital, Singapore

Phase 1/2 Not yet recruiting
36 enrolled
BreastOther solid neoplasm

HER2+ Advanced Breast Cancer

NCT06277804 2024-02-26

A Phase I Study of LTC004 Combin With FC in Patients With Advanced/Metastatic Malignancies Tumor

Letolab

Phase 1 Not yet recruiting
48 enrolled
Other solid neoplasm

Adult Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡